Related Experiment Videos
Pharmacological considerations in the modulation of multidrug resistance
G A Fisher1, B L Lum, J Hausdorff
1Division of Medical Oncology, Stanford University Medical School, California 94305, USA.
European Journal of Cancer (Oxford, England : 1990)
|June 1, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Should Therapeutic Drug Monitoring for Monoclonal Antibodies Remain the Exception or Become the Norm?
Clinical pharmacology and therapeutics·2016
Subcutaneous versus intravenous formulation of trastuzumab for HER2-positive early breast cancer: updated results from the phase III HannaH study.
Annals of oncology : official journal of the European Society for Medical Oncology·2014
A multicenter phase II study of pazopanib in patients with advanced gastrointestinal stromal tumors (GIST) following failure of at least imatinib and sunitinib.
Annals of oncology : official journal of the European Society for Medical Oncology·2013
Determination of GDC-0449, a small-molecule inhibitor of the Hedgehog signaling pathway, in human plasma by solid phase extraction-liquid chromatographic-tandem mass spectrometry.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences·2010
Multimodality treatment with intensity modulated radiation therapy for esophageal cancer.
Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2009
Phase I and pharmacokinetic study of lexatumumab (HGS-ETR2) given every 2 weeks in patients with advanced solid tumors.
Annals of oncology : official journal of the European Society for Medical Oncology·2009
Hypomethylating agents with venetoclax for newly diagnosed acute myeloid leukemia in patients 65 and older in The Netherlands - A nationwide study of drug usage and treatment outcomes.
European journal of cancer (Oxford, England : 1990)·2026
Spectral cytometry-based immune profiling coupled with machine learning identifies circulating Th1-like cells as a blood biomarker for advanced colorectal adenomas.
European journal of cancer (Oxford, England : 1990)·2026
Systemic therapies for gastroenteropancreatic neuroendocrine carcinomas: Current paradigm and future avenues.
European journal of cancer (Oxford, England : 1990)·2026
Perspectives of people affected by cancer toward generative AI in oncology: A scoping review of applications, evidence gaps, and future priorities.
European journal of cancer (Oxford, England : 1990)·2026
Incidence and survival of primary bone sarcoma diagnosed in England between 1996 and 2020; An analysis from the National Disease Registration Service.
European journal of cancer (Oxford, England : 1990)·2026
Expression patterns of potential targets for antibody-directed therapy in metastatic castration-resistant prostate cancer patients.
European journal of cancer (Oxford, England : 1990)·2026
Predicting GLP-1 Discontinuation From Pharmacy Claims.
The American journal of managed care·2026
A novel SUR1-TMD0 interaction region contributes to glucose-dependent inhibition of pancreatic KATP channels by bupropion.
British journal of pharmacology·2026